Osaic Holdings’s Immunome IMNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$37.1K Buy
1,697
+185
+12% +$4.12K ﹤0.01% 5432
2025
Q4
$32.5K Buy
1,512
+701
+86% +$12.3K ﹤0.01% 5534
2025
Q3
$9.27K Buy
811
+186
+30% +$1.85K ﹤0.01% 6411
2025
Q2
$5.81K Buy
625
+23
+4% +$189 ﹤0.01% 6462
2025
Q1
$4.05K Hold
602
﹤0.01% 6281
2024
Q4
$6.39K Sell
602
-19
-3% -$230 ﹤0.01% 6054
2024
Q3
$9.08K Buy
621
+19
+3% +$270 ﹤0.01% 5879
2024
Q2
$7.28K Hold
602
﹤0.01% 5980
2024
Q1
$14.9K Buy
+602
New +$12.2K ﹤0.01% 5521
2023
Q1
Sell
-1,229
Closed -$3K 7537
2022
Q4
$3K Hold
1,229
﹤0.01% 6509
2022
Q3
$5K Buy
+1,229
New +$5.76K ﹤0.01% 6362
2021
Q4
Sell
-100
Closed -$2K 7464
2021
Q3
$2K Sell
100
-200
-67% -$3.49K ﹤0.01% 6858
2021
Q2
$5K Hold
300
﹤0.01% 6366
2021
Q1
$10K Buy
300
+200
+200% +$4.97K ﹤0.01% 5865
2020
Q4
$1K Buy
+100
New +$1.17K ﹤0.01% 6219

Other funds holding IMNM

Osaic Holdings's IMNM Position: Q1 2026 in Review

Osaic Holdings increased its Immunome (IMNM) stake by 12% in Q1 2026, buying an estimated $4.12K and bringing the position to 1,697 shares worth $37.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5432.

Osaic Holdings first reported a position in IMNM in Q4 2020 and has held it in 15 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Osaic Holdings held 1,697 shares of Immunome worth $37.1K as of Q1 2026.
  • Osaic Holdings bought 185 Immunome shares in Q1 2026, an estimated $4.12K.
  • Immunome made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5432 holding.
  • Osaic Holdings first reported a position in Immunome in Q4 2020 and has held it in 15 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.